Patents by Inventor Joshua R. Shockey

Joshua R. Shockey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF
    Publication number: 20230133629
    Abstract: The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of metabolism (e.g., Maple Syrup Urine Disease or Urea Cycle Disorders), neurodegenerative disorders such as Parkinson's disease, spinal muscular atrophy, dystonia, or inclusion-body myositis with such compositions.
    Type: Application
    Filed: September 2, 2022
    Publication date: May 4, 2023
    Inventors: Leah E. APPEL, Joshua R. SHOCKEY, D. Christopher SCHELLING
  • Palatable compositions including sodium phenylbutyrate and uses thereof
    Patent number: 11433041
    Abstract: The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of metabolism (e.g., Maple Syrup Urine Disease or Urea Cycle Disorders), neurodegenerative disorders such as Parkinson's disease, spinal muscular atrophy, dystonia, or inclusion-body myositis with such compositions.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: September 6, 2022
    Assignee: Acer Therapeutics Inc.
    Inventors: Leah E. Appel, Joshua R. Shockey, D. Christopher Schelling
  • Methods of treating urea cycle disorders and maple syrup urine disease
    Patent number: 11202767
    Abstract: The present invention provides methods for the treatment of urea cycle disorders and Maple Syrup Urine Disease.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: December 21, 2021
    Assignee: Acer Therapeutics Inc.
    Inventors: Leah E. Appel, Joshua R. Shockey, D. Christopher Schelling
  • Palatable compositions including sodium phenylbutyrate and uses thereof
    Patent number: 11154521
    Abstract: The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of metabolism (e.g., Maple Syrup Urine Disease or Urea Cycle Disorders), neurodegenerative disorders such as Parkinson's disease, spinal muscular atrophy, dystonia, or inclusion-body myositis with such compositions.
    Type: Grant
    Filed: March 9, 2021
    Date of Patent: October 26, 2021
    Assignee: Acer Therapeutics Inc.
    Inventors: Leah E. Appel, Joshua R. Shockey, D. Christopher Schelling
  • METHODS OF TREATING UREA CYCLE DISORDERS AND MAPLE SYRUP URINE DISEASE
    Publication number: 20210220304
    Abstract: The present invention provides methods for the treatment of urea cycle disorders and Maple Syrup Urine Disease.
    Type: Application
    Filed: March 9, 2021
    Publication date: July 22, 2021
    Inventors: Leah E. APPEL, Joshua R. SHOCKEY, D. Christopher SCHELLING
  • PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF
    Publication number: 20210186908
    Abstract: The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of metabolism (e.g., Maple Syrup Urine Disease or Urea Cycle Disorders), neurodegenerative disorders such as Parkinson's disease, spinal muscular atrophy, dystonia, or inclusion-body myositis with such compositions.
    Type: Application
    Filed: March 9, 2021
    Publication date: June 24, 2021
    Inventors: Leah E. APPEL, Joshua R. SHOCKEY, D. Christopher SCHELLING
  • PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF
    Publication number: 20200261385
    Abstract: The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of metabolism (e.g., Maple Syrup Urine Disease or Urea Cycle Disorders), neurodegenerative disorders such as Parkinson's disease, spinal muscular atrophy, dystonia, or inclusion-body myositis with such compositions.
    Type: Application
    Filed: January 17, 2020
    Publication date: August 20, 2020
    Inventors: Leah E. APPEL, Joshua R. SHOCKEY, D. Christopher SCHELLING
  • PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF
    Publication number: 20170266115
    Abstract: The present invention features palatable pharmaceutical compositions including sodium phenylbutyrate and methods for the treatment of inborn errors of metabolism (e.g., Maple Syrup Urine Disease or Urea Cycle Disorders), neurodegenerative disorders such as Parkinson's disease, spinal muscular atrophy, dystonia, or inclusion-body myositis with such compositions.
    Type: Application
    Filed: October 17, 2016
    Publication date: September 21, 2017
    Inventors: Leah E. APPEL, Joshua R. SHOCKEY, D. Christopher SCHELLING
  • Multiparticulate compositions with improved stability
    Patent number: 7736672
    Abstract: A process is described for producing drug-containing multiparticulates with improved stability, characterized by an improvement in one or more of chemical stability, physical stability, or dissolution stability.
    Type: Grant
    Filed: December 3, 2004
    Date of Patent: June 15, 2010
    Assignee: Pfizer, Inc.
    Inventors: Roderick J. Ray, Leah E. Appel, Dwayne Thomas Friesen, Marshall D. Crew, Joshua R. Shockey
  • Extrusion process for forming chemically stable drug multiparticulates
    Patent number: 7625507
    Abstract: Reduced levels of drug degradation in drug-containing multiparticulates are obtained by an extrusion/melt-congeal process.
    Type: Grant
    Filed: December 3, 2004
    Date of Patent: December 1, 2009
    Assignee: Pfizer Inc.
    Inventors: Roderick J. Ray, Leah E. Appel, David D. Newbold, Dwayne T. Friesen, Scott B. McCray, David K. Lyon, James B. West, Marshall D. Crew, Joshua R. Shockey